Enliven Therapeutics, Inc.
ELVN
4 insider filings · Latest: May 18, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | May 20 4:18 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Sale | 5,000 | $39.79 | $199.0K | 25,000(D) | View → |
| Apr 17, 2026 | Apr 21 8:40 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Sale | 5,000 | $47.67 | $238.4K | 25,000(D) | View → |
| Mar 25, 2026 | Mar 27 4:57 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Sale | 40,000 | $35.10 | $1.4M | 25,000(D) | View → |
| Mar 17, 2026 | Mar 19 5:50 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Sale | 5,000 | $27.76 | $138.8K | 25,000(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 18, 2026 | May 20 4:18 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | $2.48 | 126,268(D) | View → |
| Apr 17, 2026 | Apr 21 8:40 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | $2.48 | 131,268(D) | View → |
| Mar 25, 2026 | Mar 27 4:57 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 40,000 | $2.48 | 136,268(D) | View → |
| Mar 17, 2026 | Mar 19 5:50 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | $2.48 | 176,268(D) | View → |